Medical Care
Global GPCR-targeting Drug Market Research Report 2025
- May 05, 25
- ID: 227981
- Pages: 84
- Figures: 85
- Views: 8
The global market for GPCR-targeting Drug was valued at US$ 426 million in the year 2024 and is projected to reach a revised size of US$ 508 million by 2031, growing at a CAGR of 2.6% during the forecast period.
GPCRs or G protein-coupled receptors are proteins located on the cell surface that recognize extracellular substances and transmit signals across the cell membrane. GPCRs do this by activating guanine nucleotide-binding proteins (G protein) that are responsible for signal transduction inside the cell. The signal delivery is very important in various cellular responses including cell growth, gene transcription, post-translational changes, and communication with other cells. This brings on adjustments in the body to adapt to the environmental changes such as increased heart rate when feeling threatened or change in vision in response to dim light.
North American market for GPCR-targeting Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for GPCR-targeting Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for GPCR-targeting Drug in Oncology is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of GPCR-targeting Drug include PerkinElmer, Thermo Fisher Scientific, Merck, BD Biosciences, Molecular Devices, Promega, Qiagen, Abcam, Corning, Discoverx, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for GPCR-targeting Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GPCR-targeting Drug.
The GPCR-targeting Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GPCR-targeting Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GPCR-targeting Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PerkinElmer
Thermo Fisher Scientific
Merck
BD Biosciences
Molecular Devices
Promega
Qiagen
Abcam
Corning
Discoverx
Cisbio
Segment by Type
Reagent Test Kit
Substrate
Segment by Application
Oncology
Cardiovascular
Central Nervous
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GPCR-targeting Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
GPCRs or G protein-coupled receptors are proteins located on the cell surface that recognize extracellular substances and transmit signals across the cell membrane. GPCRs do this by activating guanine nucleotide-binding proteins (G protein) that are responsible for signal transduction inside the cell. The signal delivery is very important in various cellular responses including cell growth, gene transcription, post-translational changes, and communication with other cells. This brings on adjustments in the body to adapt to the environmental changes such as increased heart rate when feeling threatened or change in vision in response to dim light.
North American market for GPCR-targeting Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for GPCR-targeting Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for GPCR-targeting Drug in Oncology is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of GPCR-targeting Drug include PerkinElmer, Thermo Fisher Scientific, Merck, BD Biosciences, Molecular Devices, Promega, Qiagen, Abcam, Corning, Discoverx, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for GPCR-targeting Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GPCR-targeting Drug.
The GPCR-targeting Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GPCR-targeting Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GPCR-targeting Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PerkinElmer
Thermo Fisher Scientific
Merck
BD Biosciences
Molecular Devices
Promega
Qiagen
Abcam
Corning
Discoverx
Cisbio
Segment by Type
Reagent Test Kit
Substrate
Segment by Application
Oncology
Cardiovascular
Central Nervous
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GPCR-targeting Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GPCR-targeting Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Reagent Test Kit
1.2.3 Substrate
1.3 Market by Application
1.3.1 Global GPCR-targeting Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global GPCR-targeting Drug Market Perspective (2020-2031)
2.2 Global GPCR-targeting Drug Growth Trends by Region
2.2.1 Global GPCR-targeting Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 GPCR-targeting Drug Historic Market Size by Region (2020-2025)
2.2.3 GPCR-targeting Drug Forecasted Market Size by Region (2026-2031)
2.3 GPCR-targeting Drug Market Dynamics
2.3.1 GPCR-targeting Drug Industry Trends
2.3.2 GPCR-targeting Drug Market Drivers
2.3.3 GPCR-targeting Drug Market Challenges
2.3.4 GPCR-targeting Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GPCR-targeting Drug Players by Revenue
3.1.1 Global Top GPCR-targeting Drug Players by Revenue (2020-2025)
3.1.2 Global GPCR-targeting Drug Revenue Market Share by Players (2020-2025)
3.2 Global GPCR-targeting Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by GPCR-targeting Drug Revenue
3.4 Global GPCR-targeting Drug Market Concentration Ratio
3.4.1 Global GPCR-targeting Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GPCR-targeting Drug Revenue in 2024
3.5 Global Key Players of GPCR-targeting Drug Head office and Area Served
3.6 Global Key Players of GPCR-targeting Drug, Product and Application
3.7 Global Key Players of GPCR-targeting Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 GPCR-targeting Drug Breakdown Data by Type
4.1 Global GPCR-targeting Drug Historic Market Size by Type (2020-2025)
4.2 Global GPCR-targeting Drug Forecasted Market Size by Type (2026-2031)
5 GPCR-targeting Drug Breakdown Data by Application
5.1 Global GPCR-targeting Drug Historic Market Size by Application (2020-2025)
5.2 Global GPCR-targeting Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America GPCR-targeting Drug Market Size (2020-2031)
6.2 North America GPCR-targeting Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America GPCR-targeting Drug Market Size by Country (2020-2025)
6.4 North America GPCR-targeting Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GPCR-targeting Drug Market Size (2020-2031)
7.2 Europe GPCR-targeting Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe GPCR-targeting Drug Market Size by Country (2020-2025)
7.4 Europe GPCR-targeting Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific GPCR-targeting Drug Market Size (2020-2031)
8.2 Asia-Pacific GPCR-targeting Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific GPCR-targeting Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific GPCR-targeting Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America GPCR-targeting Drug Market Size (2020-2031)
9.2 Latin America GPCR-targeting Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America GPCR-targeting Drug Market Size by Country (2020-2025)
9.4 Latin America GPCR-targeting Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GPCR-targeting Drug Market Size (2020-2031)
10.2 Middle East & Africa GPCR-targeting Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa GPCR-targeting Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa GPCR-targeting Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PerkinElmer
11.1.1 PerkinElmer Company Details
11.1.2 PerkinElmer Business Overview
11.1.3 PerkinElmer GPCR-targeting Drug Introduction
11.1.4 PerkinElmer Revenue in GPCR-targeting Drug Business (2020-2025)
11.1.5 PerkinElmer Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific GPCR-targeting Drug Introduction
11.2.4 Thermo Fisher Scientific Revenue in GPCR-targeting Drug Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck GPCR-targeting Drug Introduction
11.3.4 Merck Revenue in GPCR-targeting Drug Business (2020-2025)
11.3.5 Merck Recent Development
11.4 BD Biosciences
11.4.1 BD Biosciences Company Details
11.4.2 BD Biosciences Business Overview
11.4.3 BD Biosciences GPCR-targeting Drug Introduction
11.4.4 BD Biosciences Revenue in GPCR-targeting Drug Business (2020-2025)
11.4.5 BD Biosciences Recent Development
11.5 Molecular Devices
11.5.1 Molecular Devices Company Details
11.5.2 Molecular Devices Business Overview
11.5.3 Molecular Devices GPCR-targeting Drug Introduction
11.5.4 Molecular Devices Revenue in GPCR-targeting Drug Business (2020-2025)
11.5.5 Molecular Devices Recent Development
11.6 Promega
11.6.1 Promega Company Details
11.6.2 Promega Business Overview
11.6.3 Promega GPCR-targeting Drug Introduction
11.6.4 Promega Revenue in GPCR-targeting Drug Business (2020-2025)
11.6.5 Promega Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen GPCR-targeting Drug Introduction
11.7.4 Qiagen Revenue in GPCR-targeting Drug Business (2020-2025)
11.7.5 Qiagen Recent Development
11.8 Abcam
11.8.1 Abcam Company Details
11.8.2 Abcam Business Overview
11.8.3 Abcam GPCR-targeting Drug Introduction
11.8.4 Abcam Revenue in GPCR-targeting Drug Business (2020-2025)
11.8.5 Abcam Recent Development
11.9 Corning
11.9.1 Corning Company Details
11.9.2 Corning Business Overview
11.9.3 Corning GPCR-targeting Drug Introduction
11.9.4 Corning Revenue in GPCR-targeting Drug Business (2020-2025)
11.9.5 Corning Recent Development
11.10 Discoverx
11.10.1 Discoverx Company Details
11.10.2 Discoverx Business Overview
11.10.3 Discoverx GPCR-targeting Drug Introduction
11.10.4 Discoverx Revenue in GPCR-targeting Drug Business (2020-2025)
11.10.5 Discoverx Recent Development
11.11 Cisbio
11.11.1 Cisbio Company Details
11.11.2 Cisbio Business Overview
11.11.3 Cisbio GPCR-targeting Drug Introduction
11.11.4 Cisbio Revenue in GPCR-targeting Drug Business (2020-2025)
11.11.5 Cisbio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GPCR-targeting Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Reagent Test Kit
1.2.3 Substrate
1.3 Market by Application
1.3.1 Global GPCR-targeting Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global GPCR-targeting Drug Market Perspective (2020-2031)
2.2 Global GPCR-targeting Drug Growth Trends by Region
2.2.1 Global GPCR-targeting Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 GPCR-targeting Drug Historic Market Size by Region (2020-2025)
2.2.3 GPCR-targeting Drug Forecasted Market Size by Region (2026-2031)
2.3 GPCR-targeting Drug Market Dynamics
2.3.1 GPCR-targeting Drug Industry Trends
2.3.2 GPCR-targeting Drug Market Drivers
2.3.3 GPCR-targeting Drug Market Challenges
2.3.4 GPCR-targeting Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GPCR-targeting Drug Players by Revenue
3.1.1 Global Top GPCR-targeting Drug Players by Revenue (2020-2025)
3.1.2 Global GPCR-targeting Drug Revenue Market Share by Players (2020-2025)
3.2 Global GPCR-targeting Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by GPCR-targeting Drug Revenue
3.4 Global GPCR-targeting Drug Market Concentration Ratio
3.4.1 Global GPCR-targeting Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GPCR-targeting Drug Revenue in 2024
3.5 Global Key Players of GPCR-targeting Drug Head office and Area Served
3.6 Global Key Players of GPCR-targeting Drug, Product and Application
3.7 Global Key Players of GPCR-targeting Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 GPCR-targeting Drug Breakdown Data by Type
4.1 Global GPCR-targeting Drug Historic Market Size by Type (2020-2025)
4.2 Global GPCR-targeting Drug Forecasted Market Size by Type (2026-2031)
5 GPCR-targeting Drug Breakdown Data by Application
5.1 Global GPCR-targeting Drug Historic Market Size by Application (2020-2025)
5.2 Global GPCR-targeting Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America GPCR-targeting Drug Market Size (2020-2031)
6.2 North America GPCR-targeting Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America GPCR-targeting Drug Market Size by Country (2020-2025)
6.4 North America GPCR-targeting Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GPCR-targeting Drug Market Size (2020-2031)
7.2 Europe GPCR-targeting Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe GPCR-targeting Drug Market Size by Country (2020-2025)
7.4 Europe GPCR-targeting Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific GPCR-targeting Drug Market Size (2020-2031)
8.2 Asia-Pacific GPCR-targeting Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific GPCR-targeting Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific GPCR-targeting Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America GPCR-targeting Drug Market Size (2020-2031)
9.2 Latin America GPCR-targeting Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America GPCR-targeting Drug Market Size by Country (2020-2025)
9.4 Latin America GPCR-targeting Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GPCR-targeting Drug Market Size (2020-2031)
10.2 Middle East & Africa GPCR-targeting Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa GPCR-targeting Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa GPCR-targeting Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PerkinElmer
11.1.1 PerkinElmer Company Details
11.1.2 PerkinElmer Business Overview
11.1.3 PerkinElmer GPCR-targeting Drug Introduction
11.1.4 PerkinElmer Revenue in GPCR-targeting Drug Business (2020-2025)
11.1.5 PerkinElmer Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific GPCR-targeting Drug Introduction
11.2.4 Thermo Fisher Scientific Revenue in GPCR-targeting Drug Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck GPCR-targeting Drug Introduction
11.3.4 Merck Revenue in GPCR-targeting Drug Business (2020-2025)
11.3.5 Merck Recent Development
11.4 BD Biosciences
11.4.1 BD Biosciences Company Details
11.4.2 BD Biosciences Business Overview
11.4.3 BD Biosciences GPCR-targeting Drug Introduction
11.4.4 BD Biosciences Revenue in GPCR-targeting Drug Business (2020-2025)
11.4.5 BD Biosciences Recent Development
11.5 Molecular Devices
11.5.1 Molecular Devices Company Details
11.5.2 Molecular Devices Business Overview
11.5.3 Molecular Devices GPCR-targeting Drug Introduction
11.5.4 Molecular Devices Revenue in GPCR-targeting Drug Business (2020-2025)
11.5.5 Molecular Devices Recent Development
11.6 Promega
11.6.1 Promega Company Details
11.6.2 Promega Business Overview
11.6.3 Promega GPCR-targeting Drug Introduction
11.6.4 Promega Revenue in GPCR-targeting Drug Business (2020-2025)
11.6.5 Promega Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen GPCR-targeting Drug Introduction
11.7.4 Qiagen Revenue in GPCR-targeting Drug Business (2020-2025)
11.7.5 Qiagen Recent Development
11.8 Abcam
11.8.1 Abcam Company Details
11.8.2 Abcam Business Overview
11.8.3 Abcam GPCR-targeting Drug Introduction
11.8.4 Abcam Revenue in GPCR-targeting Drug Business (2020-2025)
11.8.5 Abcam Recent Development
11.9 Corning
11.9.1 Corning Company Details
11.9.2 Corning Business Overview
11.9.3 Corning GPCR-targeting Drug Introduction
11.9.4 Corning Revenue in GPCR-targeting Drug Business (2020-2025)
11.9.5 Corning Recent Development
11.10 Discoverx
11.10.1 Discoverx Company Details
11.10.2 Discoverx Business Overview
11.10.3 Discoverx GPCR-targeting Drug Introduction
11.10.4 Discoverx Revenue in GPCR-targeting Drug Business (2020-2025)
11.10.5 Discoverx Recent Development
11.11 Cisbio
11.11.1 Cisbio Company Details
11.11.2 Cisbio Business Overview
11.11.3 Cisbio GPCR-targeting Drug Introduction
11.11.4 Cisbio Revenue in GPCR-targeting Drug Business (2020-2025)
11.11.5 Cisbio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global GPCR-targeting Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Reagent Test Kit
Table 3. Key Players of Substrate
Table 4. Global GPCR-targeting Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global GPCR-targeting Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global GPCR-targeting Drug Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global GPCR-targeting Drug Market Share by Region (2020-2025)
Table 8. Global GPCR-targeting Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global GPCR-targeting Drug Market Share by Region (2026-2031)
Table 10. GPCR-targeting Drug Market Trends
Table 11. GPCR-targeting Drug Market Drivers
Table 12. GPCR-targeting Drug Market Challenges
Table 13. GPCR-targeting Drug Market Restraints
Table 14. Global GPCR-targeting Drug Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global GPCR-targeting Drug Market Share by Players (2020-2025)
Table 16. Global Top GPCR-targeting Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GPCR-targeting Drug as of 2024)
Table 17. Ranking of Global Top GPCR-targeting Drug Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by GPCR-targeting Drug Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of GPCR-targeting Drug, Headquarters and Area Served
Table 20. Global Key Players of GPCR-targeting Drug, Product and Application
Table 21. Global Key Players of GPCR-targeting Drug, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global GPCR-targeting Drug Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global GPCR-targeting Drug Revenue Market Share by Type (2020-2025)
Table 25. Global GPCR-targeting Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global GPCR-targeting Drug Revenue Market Share by Type (2026-2031)
Table 27. Global GPCR-targeting Drug Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global GPCR-targeting Drug Revenue Market Share by Application (2020-2025)
Table 29. Global GPCR-targeting Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global GPCR-targeting Drug Revenue Market Share by Application (2026-2031)
Table 31. North America GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America GPCR-targeting Drug Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America GPCR-targeting Drug Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe GPCR-targeting Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe GPCR-targeting Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific GPCR-targeting Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific GPCR-targeting Drug Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific GPCR-targeting Drug Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America GPCR-targeting Drug Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America GPCR-targeting Drug Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa GPCR-targeting Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa GPCR-targeting Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. PerkinElmer Company Details
Table 47. PerkinElmer Business Overview
Table 48. PerkinElmer GPCR-targeting Drug Product
Table 49. PerkinElmer Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 50. PerkinElmer Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific GPCR-targeting Drug Product
Table 54. Thermo Fisher Scientific Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Merck Company Details
Table 57. Merck Business Overview
Table 58. Merck GPCR-targeting Drug Product
Table 59. Merck Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 60. Merck Recent Development
Table 61. BD Biosciences Company Details
Table 62. BD Biosciences Business Overview
Table 63. BD Biosciences GPCR-targeting Drug Product
Table 64. BD Biosciences Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 65. BD Biosciences Recent Development
Table 66. Molecular Devices Company Details
Table 67. Molecular Devices Business Overview
Table 68. Molecular Devices GPCR-targeting Drug Product
Table 69. Molecular Devices Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 70. Molecular Devices Recent Development
Table 71. Promega Company Details
Table 72. Promega Business Overview
Table 73. Promega GPCR-targeting Drug Product
Table 74. Promega Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 75. Promega Recent Development
Table 76. Qiagen Company Details
Table 77. Qiagen Business Overview
Table 78. Qiagen GPCR-targeting Drug Product
Table 79. Qiagen Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 80. Qiagen Recent Development
Table 81. Abcam Company Details
Table 82. Abcam Business Overview
Table 83. Abcam GPCR-targeting Drug Product
Table 84. Abcam Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 85. Abcam Recent Development
Table 86. Corning Company Details
Table 87. Corning Business Overview
Table 88. Corning GPCR-targeting Drug Product
Table 89. Corning Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 90. Corning Recent Development
Table 91. Discoverx Company Details
Table 92. Discoverx Business Overview
Table 93. Discoverx GPCR-targeting Drug Product
Table 94. Discoverx Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 95. Discoverx Recent Development
Table 96. Cisbio Company Details
Table 97. Cisbio Business Overview
Table 98. Cisbio GPCR-targeting Drug Product
Table 99. Cisbio Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 100. Cisbio Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. GPCR-targeting Drug Picture
Figure 2. Global GPCR-targeting Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global GPCR-targeting Drug Market Share by Type: 2024 VS 2031
Figure 4. Reagent Test Kit Features
Figure 5. Substrate Features
Figure 6. Global GPCR-targeting Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global GPCR-targeting Drug Market Share by Application: 2024 VS 2031
Figure 8. Oncology Case Studies
Figure 9. Cardiovascular Case Studies
Figure 10. Central Nervous Case Studies
Figure 11. Other Case Studies
Figure 12. GPCR-targeting Drug Report Years Considered
Figure 13. Global GPCR-targeting Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global GPCR-targeting Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global GPCR-targeting Drug Market Share by Region: 2024 VS 2031
Figure 16. Global GPCR-targeting Drug Market Share by Players in 2024
Figure 17. Global Top GPCR-targeting Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GPCR-targeting Drug as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by GPCR-targeting Drug Revenue in 2024
Figure 19. North America GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America GPCR-targeting Drug Market Share by Country (2020-2031)
Figure 21. United States GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe GPCR-targeting Drug Market Share by Country (2020-2031)
Figure 25. Germany GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific GPCR-targeting Drug Market Share by Region (2020-2031)
Figure 33. China GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America GPCR-targeting Drug Market Share by Country (2020-2031)
Figure 41. Mexico GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa GPCR-targeting Drug Market Share by Country (2020-2031)
Figure 45. Turkey GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. PerkinElmer Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 50. Merck Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 51. BD Biosciences Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 52. Molecular Devices Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 53. Promega Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 54. Qiagen Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 55. Abcam Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 56. Corning Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 57. Discoverx Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 58. Cisbio Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global GPCR-targeting Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Reagent Test Kit
Table 3. Key Players of Substrate
Table 4. Global GPCR-targeting Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global GPCR-targeting Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global GPCR-targeting Drug Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global GPCR-targeting Drug Market Share by Region (2020-2025)
Table 8. Global GPCR-targeting Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global GPCR-targeting Drug Market Share by Region (2026-2031)
Table 10. GPCR-targeting Drug Market Trends
Table 11. GPCR-targeting Drug Market Drivers
Table 12. GPCR-targeting Drug Market Challenges
Table 13. GPCR-targeting Drug Market Restraints
Table 14. Global GPCR-targeting Drug Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global GPCR-targeting Drug Market Share by Players (2020-2025)
Table 16. Global Top GPCR-targeting Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GPCR-targeting Drug as of 2024)
Table 17. Ranking of Global Top GPCR-targeting Drug Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by GPCR-targeting Drug Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of GPCR-targeting Drug, Headquarters and Area Served
Table 20. Global Key Players of GPCR-targeting Drug, Product and Application
Table 21. Global Key Players of GPCR-targeting Drug, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global GPCR-targeting Drug Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global GPCR-targeting Drug Revenue Market Share by Type (2020-2025)
Table 25. Global GPCR-targeting Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global GPCR-targeting Drug Revenue Market Share by Type (2026-2031)
Table 27. Global GPCR-targeting Drug Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global GPCR-targeting Drug Revenue Market Share by Application (2020-2025)
Table 29. Global GPCR-targeting Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global GPCR-targeting Drug Revenue Market Share by Application (2026-2031)
Table 31. North America GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America GPCR-targeting Drug Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America GPCR-targeting Drug Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe GPCR-targeting Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe GPCR-targeting Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific GPCR-targeting Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific GPCR-targeting Drug Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific GPCR-targeting Drug Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America GPCR-targeting Drug Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America GPCR-targeting Drug Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa GPCR-targeting Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa GPCR-targeting Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. PerkinElmer Company Details
Table 47. PerkinElmer Business Overview
Table 48. PerkinElmer GPCR-targeting Drug Product
Table 49. PerkinElmer Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 50. PerkinElmer Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific GPCR-targeting Drug Product
Table 54. Thermo Fisher Scientific Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Merck Company Details
Table 57. Merck Business Overview
Table 58. Merck GPCR-targeting Drug Product
Table 59. Merck Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 60. Merck Recent Development
Table 61. BD Biosciences Company Details
Table 62. BD Biosciences Business Overview
Table 63. BD Biosciences GPCR-targeting Drug Product
Table 64. BD Biosciences Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 65. BD Biosciences Recent Development
Table 66. Molecular Devices Company Details
Table 67. Molecular Devices Business Overview
Table 68. Molecular Devices GPCR-targeting Drug Product
Table 69. Molecular Devices Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 70. Molecular Devices Recent Development
Table 71. Promega Company Details
Table 72. Promega Business Overview
Table 73. Promega GPCR-targeting Drug Product
Table 74. Promega Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 75. Promega Recent Development
Table 76. Qiagen Company Details
Table 77. Qiagen Business Overview
Table 78. Qiagen GPCR-targeting Drug Product
Table 79. Qiagen Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 80. Qiagen Recent Development
Table 81. Abcam Company Details
Table 82. Abcam Business Overview
Table 83. Abcam GPCR-targeting Drug Product
Table 84. Abcam Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 85. Abcam Recent Development
Table 86. Corning Company Details
Table 87. Corning Business Overview
Table 88. Corning GPCR-targeting Drug Product
Table 89. Corning Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 90. Corning Recent Development
Table 91. Discoverx Company Details
Table 92. Discoverx Business Overview
Table 93. Discoverx GPCR-targeting Drug Product
Table 94. Discoverx Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 95. Discoverx Recent Development
Table 96. Cisbio Company Details
Table 97. Cisbio Business Overview
Table 98. Cisbio GPCR-targeting Drug Product
Table 99. Cisbio Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)
Table 100. Cisbio Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. GPCR-targeting Drug Picture
Figure 2. Global GPCR-targeting Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global GPCR-targeting Drug Market Share by Type: 2024 VS 2031
Figure 4. Reagent Test Kit Features
Figure 5. Substrate Features
Figure 6. Global GPCR-targeting Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global GPCR-targeting Drug Market Share by Application: 2024 VS 2031
Figure 8. Oncology Case Studies
Figure 9. Cardiovascular Case Studies
Figure 10. Central Nervous Case Studies
Figure 11. Other Case Studies
Figure 12. GPCR-targeting Drug Report Years Considered
Figure 13. Global GPCR-targeting Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global GPCR-targeting Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global GPCR-targeting Drug Market Share by Region: 2024 VS 2031
Figure 16. Global GPCR-targeting Drug Market Share by Players in 2024
Figure 17. Global Top GPCR-targeting Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GPCR-targeting Drug as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by GPCR-targeting Drug Revenue in 2024
Figure 19. North America GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America GPCR-targeting Drug Market Share by Country (2020-2031)
Figure 21. United States GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe GPCR-targeting Drug Market Share by Country (2020-2031)
Figure 25. Germany GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific GPCR-targeting Drug Market Share by Region (2020-2031)
Figure 33. China GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America GPCR-targeting Drug Market Share by Country (2020-2031)
Figure 41. Mexico GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa GPCR-targeting Drug Market Share by Country (2020-2031)
Figure 45. Turkey GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. PerkinElmer Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 50. Merck Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 51. BD Biosciences Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 52. Molecular Devices Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 53. Promega Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 54. Qiagen Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 55. Abcam Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 56. Corning Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 57. Discoverx Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 58. Cisbio Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232